Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells
about
Siglecs in the immune systemCD22: an inhibitory enigmaSialic acid binding domains of CD22 are required for negative regulation of B cell receptor signalingA novel epitope from CD22 regulates Th1 and Th17 cell function in systemic lupus erythematosusIn situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone.Characterization of CD22 expression in acute lymphoblastic leukemiaCD22 is required for formation of memory B cell precursors within germinal centers.Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.CD22 is required for protection against West Nile virus Infection.CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactionsRegulation of B-cell entry into the cell cycleDendritic cell-dependent inhibition of B cell proliferation requires CD22Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts.CD22 binds B-cell receptorCD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
P2860
Q24682458-4AA15DAB-1D64-4FA7-85DD-36917F418FFEQ28260435-9A8CC1B8-5357-462F-8D20-3D94BC1B99E0Q28613809-231005BB-89CA-49BD-852E-EE7C67D00613Q31118181-446C0669-DE54-4B55-AF0B-A2FC37C1711CQ33883072-A946DA2B-7A71-4FCA-B91C-5DA722570A9FQ34995766-3F64DA55-6672-4311-93D5-5686CD2ABD9DQ35514128-E9787441-3A9E-4073-A76C-8DE2D999C9E1Q36323954-040E522C-4EBB-4B9C-BD2A-2426C8E32E30Q36491551-48E3F919-5B4C-4230-B137-D827A8822245Q36667984-5AA9AEDB-4D26-4C0F-A26F-A196568B6E2BQ37173667-B620FD7E-FE39-492D-BE37-2D2F1543A98EQ37256980-71A02349-3B17-4998-9AA1-D0BEC6CEC2F1Q37308334-B5F84A59-32B4-442F-81B4-B1EE7CDD28BAQ37647125-1B2EC038-C6E0-40B6-B85A-E06FDFC60022Q38931196-0024BE12-2CF1-47D3-9F45-7E8605FDB4CFQ39852397-2ABC70A0-E00F-4FBC-A1EB-0482B406BA94Q50291506-5D6B3BBD-C080-497B-818D-86E8E71D1E23Q57490095-778DE1A5-D21E-49C8-A7B6-04996EA78B6A
P2860
Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells
description
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
im Oktober 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1995/10/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/10/01)
@nl
наукова стаття, опублікована в жовтні 1995
@uk
مقالة علمية (نشرت في أكتوبر 1995)
@ar
name
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@ast
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@en
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@nl
type
label
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@ast
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@en
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@nl
prefLabel
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@ast
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@en
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@nl
P2093
P1476
Ig domains 1 and 2 of murine C ...... nds expressed on B and T cells
@en
P2093
E. A. Clark
K. A. Chandran
R. T. Doty
P304
P407
P577
1995-10-01T00:00:00Z